HZ

Hancheng ZHANG

HC Hangzhou Innogate Pharma Co.: 10 patents #1 of 5Top 20%
VC Vivo Mobile Communication Co.: 1 patents #232 of 599Top 40%
Overall (All Time): #433,167 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12415797 Heterocyclic compound as CDK-HDAC double-channel inhibitor Xiangyang YE, Xin Cheng 2025-09-16
12358911 Heterocyclic comipound as CDK-HDAC dual pathway inhibitor Xiangyang YE, Xin Cheng 2025-07-15
12236081 Verification method, electronic device, and non-transitory computer-readable storage medium Yongfa Zhang 2025-02-25
11352353 Heterocyclic compound serving as FGFR4 inhibitor Shifeng Liu, Xiangyang YE 2022-06-07
11266640 Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor Xiangyang YE 2022-03-08
11225492 Heterocycles useful as anti-cancer agents Shifeng Liu 2022-01-18
11142535 Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor Shifeng Liu, Xiangyang YE, Wenting Chen 2021-10-12
10968234 Compound containing tricyclic heteroaryl group Shifeng Liu, Xiangyang YE 2021-04-06
10934311 Heterocyclic compound used as FGFR inhibitor Shifeng Liu 2021-03-02
10730887 Compound containing tricyclic heteroaryl group Shifeng Liu, Xiangyang YE 2020-08-04
10358451 Heterocycles useful as IDO and TDO inhibitors Shifeng Liu 2019-07-23